| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 109.520 | 117.903 | 120.320 | 127.978 | 133.200 | 134.513 | 96.836 | 118.527 | 138.792 | 135.098 |
| Total Income - EUR | 109.520 | 118.192 | 120.335 | 128.452 | 133.206 | 134.513 | 96.836 | 118.688 | 138.854 | 135.230 |
| Total Expenses - EUR | 103.990 | 112.628 | 117.395 | 125.983 | 129.031 | 132.377 | 93.714 | 113.123 | 137.502 | 135.607 |
| Gross Profit/Loss - EUR | 5.530 | 5.564 | 2.940 | 2.469 | 4.175 | 2.136 | 3.122 | 5.565 | 1.352 | -376 |
| Net Profit/Loss - EUR | 4.627 | 4.810 | 1.803 | 1.184 | 2.839 | 895 | 2.228 | 4.519 | 157 | -3.466 |
| Employees | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Hema Spicul Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.552 | 6.148 | 4.187 | 3.093 | 16.126 | 12.748 | 19.392 | 15.555 | 12.527 | 12.113 |
| Current Assets | 12.269 | 11.249 | 13.688 | 19.115 | 8.452 | 9.807 | 19.103 | 32.844 | 43.178 | 54.804 |
| Inventories | 7.190 | 6.052 | 6.442 | 5.482 | 6.003 | 5.416 | 19.509 | 39.753 | 54.505 | 51.556 |
| Receivables | 62 | 469 | 461 | 11.878 | 1.201 | 523 | 1.816 | 1.502 | 742 | 1.781 |
| Cash | 5.018 | 4.728 | 6.784 | 1.755 | 1.248 | 3.868 | -2.222 | -8.411 | -12.069 | 1.468 |
| Shareholders Funds | 12.667 | 11.112 | 12.727 | 13.678 | 16.252 | 16.839 | 18.693 | 23.270 | 23.357 | 19.760 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.154 | 6.285 | 5.148 | 8.530 | 8.326 | 5.716 | 19.801 | 25.129 | 32.349 | 47.158 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Hema Spicul Srl